Home/ Stocks/ MBRX

Moleculin Biotech, Inc.

MBRX XNAS

$8.70 -0.03 (-0.34%) ▼ 15-min delayed

Open

$8.88

High

$8.94

Low

$8.53

Volume

14.3K

Market Cap

$8.87M

About Moleculin Biotech, Inc.

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 17 Website →

Related Market News

No specific coverage for MBRX yet. Check out our latest market news or earnings calendar.

Get MBRX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Moleculin Biotech, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.